Seminars in Respiratory and Critical Care Medicine

LinksSchließen

Referenz

Bleecker ER, FitzGerald JM, Chanez P. , et al; SIROCCO study investigators.
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.

Lancet 2016;
388 (10056): 2115-2127

Bibliographische Angaben herunterladen

Aufrufen in: